Delivery Order SPE2DB25D3201-SPE2DB25FNTQY

Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,181.34 delivery order contract is for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,567.20 firm fixed-price delivery order is for the supply of VYVANSE 40 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is a delivery order for $1,329.33 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568222218 VYVANSE 40 MG CAPSULE 100S, a neurological medication, with a performance period through May 13, 2025. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,416.77, is a delivery order for the supply of VYVANSE 40 MG CAPSULE 100S. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,723.38 firm fixed-price delivery order is for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is a delivery order valued at $2,358.88 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 40 MG CAPSULE 100S, a prescription medication, with a performance period through February 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,721.40 firm fixed-price delivery order is for the supply of 4567174831 VYVANSE 40 MG CAPSULE 100S. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,059.88 fixed-price delivery order is for the supply of VYVANSE 40 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,059.88 firm fixed-price delivery order is for the supply of VYVANSE 70 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,570.62 Firm Fixed Price Delivery Order contract is for the supply of VYVANSE CAPS 70MG, a prescription medication. The contract has an ultimate completion date of March 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNTQY
    Delivery Order

This federal contract award is a delivery order valued at $3,487.27, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 40 MG CAPSULE 100S, a neurological medication. The delivery order has a firm fixed price and an ultimate completion date of June 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard. This specific delivery order is not designated as a set-aside contract.

Generated 9/2/25, 9:49 AM